From worms to mammals to clinical trials
On the path to FDA regulatory approval, therapeutics identified in worms are validated in cell culture and small mammal models with the help of our academic partners. Based on the indication and clinical endpoints pursued, clinical trials will be performed in humans or in companion animals. We are paying close attention to the Dog Aging Project TRIAD trial and will design our trials based on insights from this study.